Literature DB >> 21118398

Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.

Andrew King1, Satomi Maekawa, Istvan Bodi, Claire Troakes, Safa Al-Sarraj.   

Abstract

Frontotemporal lobar degeneration with TDP-43-positive inclusions (FTLD-TDP), frontotemporal lobar degeneration with motor neuron disease/amyotrophic lateral sclerosis (FTLD-MND/ALS) and MND/ALS are thought to represent a clinicopathological spectrum of TDP-43 proteinopathies. The cerebellum has been little studied in these conditions, probably because of the lack of cerebellar signs in most cases. We examined p62 immunohistochemistry on cerebellar sections from 43 TDP-43 proteinopathies (including cases of FTLD-TDP, FTLD-MND/ALS and MND/ALS) together with 72 cases of other neurodegenerative diseases, seven controls and three other disease conditions. In 11 of the TDP-43 proteinopathies (26%) there were numerous p62-positive cerebellar inclusions, predominantly within the granular layer, but also the molecular and Purkinje cell layer. Furthermore, only one of the remaining 82 cases (a familial tauopathy) showed similar p62 positivity. Immunohistochemistry for ubiquitin was positive in the granular layer inclusions. The immunohistochemistry for phosphorylation-independent TDP-43, hyperphosphorylated tau, α-synuclein, fusion sarcoma protein (FUS), and neurofilament was negative. In only one case (a case of FTLD-TDP) were the inclusions positive for phosphorylation-dependent TDP43 (p-TDP-43). Those TDP-43 proteinopathy cases that showed the cerebellar inclusions also tended to display other common features, such as a notable excess of p62 pathology when compared to TDP-43 pathology, especially within the pyramidal neurones of the hippocampus but also in some cases within the neocortex. The results suggest that p62-positive inclusions within the cerebellum are seen in a proportion of cases across the range of the TDP-43 proteinopathy spectrum and they appear to be relatively specific for this group of diseases. The question as to whether these cerebellar-positive cases represent a distinct subgroup remains to be answered. Furthermore, the relationship of the p62 positivity in the cerebellum to the underlying pathological processes awaits to be established.
© 2010 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118398     DOI: 10.1111/j.1440-1789.2010.01171.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  29 in total

Review 1.  The Genetics of C9orf72 Expansions.

Authors:  Ilse Gijselinck; Marc Cruts; Christine Van Broeckhoven
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

2.  Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.

Authors:  Johannes Brettschneider; Vivianna M Van Deerlin; John L Robinson; Linda Kwong; Edward B Lee; Yousuf O Ali; Nathaniel Safren; Mervyn J Monteiro; Jon B Toledo; Lauren Elman; Leo McCluskey; David J Irwin; Murray Grossman; Laura Molina-Porcel; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-03-18       Impact factor: 17.088

3.  Regulation of autophagy by neuropathological protein TDP-43.

Authors:  Jayarama Krishnan Bose; Chi-Chen Huang; C-K James Shen
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

4.  Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.

Authors:  Ging-Yuek R Hsiung; Mariely DeJesus-Hernandez; Howard H Feldman; Pheth Sengdy; Phoenix Bouchard-Kerr; Emily Dwosh; Rachel Butler; Bonnie Leung; Alice Fok; Nicola J Rutherford; Matt Baker; Rosa Rademakers; Ian R A Mackenzie
Journal:  Brain       Date:  2012-02-17       Impact factor: 13.501

5.  Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation.

Authors:  Eileen H Bigio; Sandra Weintraub; Rosa Rademakers; Matt Baker; Saman S Ahmadian; Alfred Rademaker; Bing Bing Weitner; Qinwen Mao; Kyung-Hwa Lee; Manjari Mishra; Rakhee A Ganti; M-Marsel Mesulam
Journal:  Neuropathology       Date:  2012-06-18       Impact factor: 1.906

6.  C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathology.

Authors:  Eileen H Bigio
Journal:  Acta Neuropathol       Date:  2011-12       Impact factor: 17.088

7.  Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation.

Authors:  Veronica H Ryan; Gregory L Dignon; Gül H Zerze; Charlene V Chabata; Rute Silva; Alexander E Conicella; Joshua Amaya; Kathleen A Burke; Jeetain Mittal; Nicolas L Fawzi
Journal:  Mol Cell       Date:  2018-01-18       Impact factor: 17.970

8.  Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study.

Authors:  Elliott J Mufson; Sylvia E Perez; Muhammad Nadeem; Laura Mahady; Nicholas M Kanaan; Eric E Abrahamson; Milos D Ikonomovic; Fiona Crawford; Victor Alvarez; Thor Stein; Ann C McKee
Journal:  Brain Inj       Date:  2016       Impact factor: 2.311

Review 9.  Mechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases.

Authors:  Charleen T Chu
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

10.  Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.

Authors:  H-J Kim; S-I Oh; M de Leon; X Wang; K-W Oh; J-S Park; A Deshpande; M Buj; S H Kim
Journal:  Eur J Neurol       Date:  2016-10-18       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.